The clinical usefulness of high dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy

Brain and Nerve

Volumn 51, Issue 2, 1999, Pages 127-135

  Kubori, Tamotsu ^a   Mezaki, Takahiro ^a   Kaji, Ryuji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

CIDI" (chronic inflammatory demyelinating polyneuropathy); Intravenous imrnunoglobulin therapy; MMN (multifocal motor neuropathy); Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN;

ARTICLE; BRAIN INFARCTION; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMYELINATING DISEASE; DRUG MEGADOSE; FEVER; HEMIPARESIS; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MOTOR NEUROPATHY; NERVE CONDUCTION; POLYNEUROPATHY; RANDOMIZED CONTROLLED TRIAL; RASH; SENSORY NERVE; THALAMUS;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; DEMYELINATING DISEASES; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; ELECTROPHYSIOLOGY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; MOTOR NEURON DISEASE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYNEUROPATHIES;

EID: 0033061867     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Dyck PJ, Lais AC, Ohta M, et al : Chronic inflammatory polyradiculopathy. Mayo Clin Proc 50 : 621, 1975
2. Lewis RA, Sumner AJ, et al : Multifocal demyelinating neuropathy with persistent conduction block. Neurology 32 : 958, 1982
3. van Doom PA, Vermeiden M, Brand A, et al : Intravenous human immunoglobulin treatment in patients with chronic inflammatory polyneuropathy. Arch Neurol 48: 217-220, 1991
4. Kaji R, Shibasaki H, et al : Multifocal demyelinating motor neuropathy : Cranial nerve involvement and immunoglobulin therapy. Neurology 42 : 506, 1992
5. Vermeiden M, van Doom PA, Brand A, et al : Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy : A double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 56 : 36 39, 1993
6. Van Daele MC, Wijndaele L, Hunninck K : Intravenous immune globulin and acute aseptic meningitis. N Engl J Med 323: 614 615, 1990
7. Chan-Lam D, Fitzsimons EJ, et al : Alopecia after immunoglobulin infusion. Lancet 1 : 1436, 1987
8. Ayliffe W, Ilaeney M, et al : Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy. Lancet 339 : 558, 1992
9. Silbert PL, Knezevic VVV, Bridge DT : Cerebral infarction complicating intravenous iinmunoglobulin therapy for polyneuritis craninlis. \eurology 42 : 257 258, 1992
10. Steg RK. Lefkowitz DM: Cerebral infarction following intravenous immunoglobulin therapy for inyasthenia gravis. Neurology 41 : 1180- 1181. 1994
11. Woodruff KF, Grigg AP, Firkin FC, et al: Fatal thromotic events during treatment of autoimmune : Thrombocytopenia with intravenous immunoglobulin in elderly patients. Lancet 26: 217 218, 1986
12. Reinhart WII, Berchtold PE: Effect of high dose intravenous immunoglobulin therapy on blood rheology. Lancet 339 : 662-664, 1992